A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration

NCT02121522 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: BI 144807

Sponsor

Boehringer Ingelheim